ONYX PHARM (NASDAQ:ONXX)
29.05
+0.59 (2.07%)
| ONYX PHARM (NASDAQ:ONXX) Delayed : |
| Previous Close |
$28.46 |
|
52 Week High |
$36.75 |
|
| Open |
$28.77 |
|
52 Week Low |
$21.85 |
| Day High |
$29.53 |
|
P/E |
N/A |
| Day Low |
$28.40 |
|
EPS |
$-0.17 |
| Volume |
694,407 |
|
|
|
| More ONXX Info:
Chart
SEC Filings
Profile
Historical
Options
|
View All ReportsStreetInsider.com Reports on ONXX
-
Feb 3, 2010 08:27 AM
Brean Murray Initiates Coverage on Onyx Pharmaceuticals (ONXX); Benefits Outweigh Risks, Two Potential Blockbusters
-
Feb 2, 2010 08:03 AM
Onyx Pharma (ONXX) Reaches Agreement with FDA on SPA for Phase 3 Trial of Carfilzomib
-
Jan 6, 2010 05:30 PM
Morgan Stanley Gives a Preview for Biotech's Q4 Earnings (GILD, CELG, BIIB, GENZ, More...)
-
Dec 14, 2009 09:00 AM
Onyx Pharma (ONXX) and Bayer HealthCare Presented Data on Two Nexavar Phase 2's at SABCS
-
Dec 7, 2009 07:19 AM
Onyx Pharma (ONXX) Updates Safety Data for Phase 2b of Carfilzomib
View All Reports
StreetInsider Reports on ONXX by Category
Comments on recent ONXX articles
Comments on ONXX
No comments are currently available.
on Jan 6, 2010
at 05:59 PM GILD Man, that Morgan Stanley analyst sure hates him some Gilead. He may or may not be right about the pipeline, but the share price already reflects his concerns and then some.
Article: Morgan Stanley Gives a Preview for Biotech's Q4 Earnings (GILD, CELG, BIIB, GENZ, More...)
on Nov 13, 2009
at 03:55 PM ANDREW OLIVER SATCHELL EXCELLENT
Article: Trading Radar for 11/03: UBS (UBS), Yamana Gold (AUY), Archer-Daniels (ADM), Royal Caribbean (RCL), Marathon (MRO) Report